SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and internationally. The company is headquartered in Santa Clara, California.
| Revenue (TTM) | $206.22M |
| Gross Profit (TTM) | $164.13M |
| EBITDA | $-13.83M |
| Operating Margin | -9.69% |
| Return on Equity | -9.65% |
| Return on Assets | -5.30% |
| Revenue/Share (TTM) | $4.75 |
| Book Value | $4.05 |
| Price-to-Book | 3.64 |
| Price-to-Sales (TTM) | 3.16 |
| EV/Revenue | 2.664 |
| EV/EBITDA | -14.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.20% |
| Shares Outstanding | $44.35M |
| Float | $42.87M |
| % Insiders | 3.28% |
| % Institutions | 108.07% |
Volatility is currently expanding